Identifying mutations that cause specific osteochondrodysplasias will provide novel insights into the function of genes that are essential for skeletal morphogenesis. We report here that an autosomal dominant form of Stickler syndrome, characterized by mild spondyIoepiphyseal dysplasia, osteoarthritis, and sensorineural hearing loss, but no eye involvement, is caused by a splice donor site mutation resulting in "in-frame" exon skipping within the COLllA2 gene, encoding the a2(XI) chain of the quantitatively minor fibrillar collagen XI. We also show that an autosomal recessive disorder with similar, but more severe, characteristics is linked to the COL 11A2 locus and is caused by a glycine to arginine substitution in a2(XI) collagen. The results suggest that mutations in collagen XI genes are associated with a spectrum of abnormalities in human skeletal development and support the conclusion of others, based on studies of murine chondrodysplasia, that collagen XI is essential for skeletal morphogenesis.
Introduction
Molecular genetic analyses of osteochondrodysplasias, hereditary disorders affecting skeletal development in both mice and humans, promise to provide insights into the large number of genes essential for skeletal morphogenesis. With improved techniques for gene mapping, positional cloning, functional cloning, and mutation detection, the task of identifying the mutations causing these disorders is becoming less daunting. This is illustrated by the recent successes in identifying mutations in genes encoding structural, growth factor receptor, and sulfate transporter proteins as causes of distinct osteochondrodysplasias (Warman et al., 1993; Shiang et al., 1994; Reardon et al., 1994; H&stbacka et al., 1994) . Adding to this is the accompanying paper by Li et al. (1995 [this issue of Cell]), which demonstrates that autosomal recessive chondrodysplasia (cho) in mice is due to a mutation in the gene, Collla 1, coding for one of the polypeptide subunits of the quantitatively minor fibrillar collagen XI in cartilage.
Collagen Xl molecules are heterotrimers of three distinct subunits, a l(Xl), ~2(Xl), and cx3(Xl), encoded by Co111al, Co111a2, and Col2al, respectively (Eyre and Wu, 1987) . Analysis of cho mice demonstrates that the absence of ~I(Xl) collagen chains, and therefore collagen Xl heterotrimers, leads to a severe disruption of the columnar arrangement and maturation of growth plate chondrocytes, abnormalities in collagen fibril diameter, and reduced cohesive strength of cartilage matrices (Li et al., 1995) . These data suggest that the Col1 lal gene is essential for skeletal morphogenesis.
Here, we report that the COL11A2 locus, encoding the a2(Xl) subunit of collagen Xl, is associated with autosomal dominant and autosomal recessive human osteochondrodysplasias. We describe a mutation affecting a 5' splice site leading to in-frame exon skipping and causing an autosomal dominant form of Stickler syndrome. We also show that an autosomal recessive disorder characterized by spondyloepiphyseal dysplasia and sensorineural hearing loss, similar to the otospondylomegaepiphyseal dysplasia (OSMED) syndrome, is linked to the COL11A2 locus and is caused by a glycine to arginine substitution in ~2(Xl) collagen. These data suggest that mutations affecting collagen Xl can cause a spectrum of clinical phenotypes and that collagen Xl is essential also for human skeletal morphogenesis.
Results

Identification of the COL11A2 Mutation in a Family with Stickler Syndrome
We recently described linkage to markers near the COLllA2 locus in a large Dutch kindred with a Stickier syndrome phenotype (Bru nner et al., 1994 (Stickler et al., 1965) combined with hearing impairment. Several patients had cleft palate and mild arthropathy, but none had the ophthalmological signs usually associated with the Stickler syndrome. To identify the mutation causing the disorder in this family, we used reverse transcription-polymerase chain reaction (RT-PCR) from total RNA extracted from chondrocytes and EpsteinBarr virus-transformed (EBV-transformed) lymphoblasts from patients heterozygous for the defective allele and from unaffected individuals. Primers for nested PCR were designed to cover, in five overlapping fragments, the whole coding sequence (4953 bp) of the ct2(Xl) collagen gene. Restriction enzymes were used to cut these 33P-labeled amplification products into several smaller fragments to enhance the likelihood of detecting differences between the patient and the control samples. The digested fragments were analyzed on MDE (AT Biochem) and single-strand conformation polymorphism (SSCP) gels. SSCP shifts and heteroduplexes were identified, and the corresponding fragments were sequenced. Several neutral polymorphisms and a double-sequence caused by deletion of 54 nucleotides were observed. Since the deletion corresponded to an exon in the triple-helical region of the ~2(XI) gene, we tested the hypothesis that the deleted sequence represented a skipped exon during RNA splicing of ~2(Xl) transcripts. A novel primer pair was synthesized according to the sequences of exons adjacent to the skipped exon, and the corresponding region was amplified using patient genomic DNA as a template. Cycle-sequencing of this PCR product revealed heterozygosity for a 1 bp change at the exon-intron boundary such that the intronic donor-site sequence, GTGAG, was replaced by ATGAG ( Figure 1 ). This change created a novel Nlalll site in the genomic sequence. To demonstrate that this sequence change was present in all the affected individuals, genomic DNAs of all family members were PCR amplified, the sense primer being end-labeled with 32p. After Nlalll digestion, these products were run on 5% denaturing sequencing gels. The G to A transition cosegregated with the disease (Figure 2 ).
Linkage between an Autosomal Recessive Phenotype and Loci on Chromosome 6p
A second Dutch kindred has been identified, in which three affected siblings have severe degenerative joint disease (osteoarthritis), which presents in early adulthood and affects predominantly the hips, knees, elbows, and shoulders ( Figure 3 ). The spine is less severely affected, and adult height is only slightly below that of the unaffected siblings. There is increased lumbar lordosis and prominent interphalangeal joints. Short fifth metacarpals are found in all cases. The patients have distinct facial features: midface hypoplasia with a short upturned nose, prominent eyes, depressed nasal bridge, and prominent supraorbital The affected siblings were found to be homozygous for an extended haplotype of seven CA (dinucleotide) repeat polymorphisms from chromosome 6p21 near the COL11A2 locus ( Figure 4A ). If the consanguinity loop was ignored, a maximum Iod score of 1.45 without recombination was obtained for those markers that were fully informative were obtained, however, when the consanguinity loop was taken into account. Since for most of these markers allele frequencies are not available from the Dutch population and the frequency of the abnormal allele is also unknown, the Iod score calculations were performed with a range of parametric values. Conservative estimates of 0.002 for the abnormal allele and 0.005 for the marker haplotype yielded a Iod score of 3.09 at ® = 0.0.
Incorporation of COLllA2 into the Human Linkage Map
Pairwise linkage analyses for COL 11A2 and loci on human chromosome 6 were performed to place the COL11A2 gene into the human linkage map. As a marker for the (Volz et al., 1994 ) and the second-generation Genethon map (Gyapay et al., 1994) .
It should be noted that the relationship between D6S291 and COL11A2 is based on only 10 meioses within three Centre d'Etudes du Polymorphisme Humain (CEPH) pedigrees informative for both loci.
In the family with recessive osteochondrodysplasia, patient number 6 has a recombination between D6S273 and D6S291 (see Figure 4A ). Since we did not observe any recombinations between the COL11A2 gene and the D6S291 marker in the three informative CEPH families, we wanted to confirm that the gene is within the inherited haplotype. We have recently identified a novel polymorphism within the COL11A2 gene that creates an Mspl restriction site. A 180 bp genomic fragment containing this polymorphism was amplified from all family members. Both parents are heterozygous, and all children are homozygous for the two alleles identified, thus placing the observed recombination in patient number 6 centromeric to COL11A2, between the gene and the marker D6S291 (see Figure 4A ).
Identification of the COL11A2 Mutation in the Family with Autosomal Recessive Osteochondrodysplasia
To find the mutation causing the autosomal recessive disorder, we used RT-PCR with total RNA extracted from g Locus log 10 probability COLllA2. The log 10 order probability for adjacent loci is indicated.
®, sex average recombination frequency.
EBV-transformed lymphoblasts derived from parents and affected individuals. Several overlapping fragments were generated, and the complete coding sequence of the ~2(Xl) collagen gene was determined for one individual. This identified a G to A transition, converting a glycyl to an arginyl codon, within the triple-helical domain of ~2(Xl) collagen. This change in sequence eliminated an Mspl restriction site within the genomic sequence. To demonstrate that this sequence change was present in all the affected individuals, genomic DNAs of all family members were PCR amplified, and the products were electrophoresed through a 4% agarose gel after digestion with Mspl (see Figure 4A ). The affected children showed the absence of the Mspl site. A similar analysis with DNA from 63 unrelated parents (corresponding to 126 chromosomes) of CEPH families showed the presence of this Mspl site in all samples (data not shown), thus excluding the possibility that the G to A sequence change represented a common polymorphism. Finally, cycle sequencing of these genomic PCR products demonstrated that affected children are homozygous for the arginyl codon, while unaffected children are homozygous for the glycyl codon; both parents are heterozygous for the sequence change (see Figure 4B) .
Discussion
We present evidence that the COL 71A2 gene is associated with both autosomal dominant and autosomal recessive human osteochondrodysplasias. These data suggest that collagen Xl is essential for norma~ skeletal development, in agreement with the conclusions of Li et al. (1995) in their accompanying paper.
A Mutation in COLllA2 Causes Autosomal Dominant Stickler Syndrome without Eye Involvement
We have identified a G to A transition at a splice donor site within the COL11A2 gene, which cosegregates with an autosomal dominant Stickler syndrome phenotype in a large family. In vitro splicing experiments have previously demonstrated the importance of the five conserved nucleotides at the splice donor site for efficient and correct splicing of mRNA (Talerico and Berget, 1990) , and similar mutations in (~1(I) and (~2(I) collagen genes have been implicated in other osteochondrodysplasias (reviewed by Kuivaniemi et al., 1991) . The present mutation causes in-frame skipping of a 54 bp exon, encoding 18 amino acid residues within the triple helical domain of the (z2(Xl) collagen molecule (Figure 1 ). Approximately 50% of the COL11A2 mRNA transcripts recoverable by RT-PCR from patient chondrocytes and EBV-transformed lymphoblasts contain the deleted exon (data not shown), suggesting that the mutation does not significantly affect mRNA stability. The mutated polypeptide chain may therefore be synthesized at a level comparable to that of the wild-type chain. Mutant (~2(Xl) chains would be 18 amino acid residues shorter than wild-type chains, but would contain the intact sequence of the carboxy-terminal propeptide domain. In fibrillar procollagens, including collagen Xl, chain association during trimer assembly initiates at the carboxy-terminal propeptide domain (Dolz and Engel, 1990) . Therefore, mutant (~2(Xl) chains are likely to associate with (~I(Xl) and (z3(Xl) chains during trimer assembly. Once associated, however, the 18 amino acid deletion within the triplehelical domain is likely to interfere with normal triple helix formation. Whether the phenotypic effect of this mutation is due to the rapid degradation of abnormally folded heterotrimers causing a deficiency of collagen Xl or whether it is a consequence of copolymerization of abnormal molecules with normal collagen II, IX, and Xl molecules in cartilage collagen fibrils requires further study. 
A C01.11A2 Mutation Is Also the Cause of the Autosomal Recessive Phenotype
The three affected patients in the consanguineous family with autosomal recessive osteochondrodysplasia appear homozygous by descent for an interval defined by seven chromosome 6p21 CA repeat markers, within which we have mapped the COL11A2 gene ( Figure 4A ). Using conservative estimates for mutant allele frequency (0.002) and extended haplotype frequency (0.005), a Iod score of 3.09 with the COLllA2 locus was obtained.
The phenotype of the affected members in this family, although more severe, resembles that of the family with the dominantly inherited COL11A2 splice site mutation (Table 1) . It also shares similarites with the OSMED syndrome (Giedion et al., 1982) , which itself shares radiographic features with Stickler syndrome (Spranger, 1985) . The clinical similarity among these disorders and the evidence of linkage to the COL11A2 locus in our family strongly suggested that a mutation in COL11A2 was responsible for the autosomal recessive phenotype as well.
The COL11A2 mutation causing the autosomal recessive phenotype is likely to affect the stability of heterotrimeric collagen Xl molecules since it changes a glycyl residue in a Gly-X-Y triplet to arginine. The location of the mutation within the triple-helical domain of ~2(Xl) collagen suggests that it creates, like the mutation in the autosomal dominant Stickler syndrome, a mutant polypeptide capable of participating in trimer assembly. This raises the question of why heterozygous "carrier" parents for the glycine to arginine mutation are asymptomatic, while the heterozygotes for the exon-skipping mutation show a clinical abnormality. We suggest that a possible reason for this difference is that substituting arginine for glycine close to the amino terminus of collagen Xl molecules may still allow incorporation of mutated molecules into cartilage fibrils and therefore may allow some residual function, while a large in-frame deletion close to the carboxyl end of the molecule causes a complete disruption of triple-helical folding and function. Supporting evidence for this comes from mice heterozygous for the cho mutation (a functional null allele in Co111al) that are asymptomatic, suggesting that a reduction in the level of functional collagen XI may not be clinically apparent. In contrast, however, homozy-gosity for the cho mutation, leading to complete deficiency of Co/11al, has profound phenotypic consequences (Li et al., 1995) .
In the mice, homozygosity for a functional null mutation in Co/11al results in a perinatal lethal chondrodysplasia.
A partial loss of function would explain why the recessive mutation in COL11A2 is not likewise lethal. In addition, there is a difference in utilization of al(XI) and a2(XI) chains within type Xl collagen heterotrimeric molecules.
In mammalian vitreous, the COL5A2 gene product, a2(V), replaces ~2(XI), forming a collagen V/XI hybrid molecule (Mayne et al., 1993) . This most likely accounts for the lack of eye involvement associated with COL 11A2 mutations and could lessen the effects of a COL11A2 mutation if a similar substitution also occurs in extraocular tissues. It is interesting to note that both parents in the family with the recessive syndrome did not show clinical abnormalities in articular cartilage, although there appears to be a history of osteoarthritis on the paternal side of the family. This obviously raises the possibility that mutations in collagen XI genes similar to the one described here may represent a predisposing factor in osteoarthritis.
Experimental Procedures
Analysis of the COL11A2 Gene RNA was extracted from EBV-transformed lymphoblasts or chondrocytes following the protocol of the REX total RNA extraction kit (U. S. Biochemical). One to two micrograms of total RNA was used as template for reverse transcription using the Superscript Preamplification System (GIBCO BRL). Oligo(dr)s or random hexamers were used as primers for the cDNA synthesis.
For analysis of the dominant syndrome, PCR primers were designed to amplify the approximately 4.95 kb cDNA in five overlapping fragments. Nested primers were used for second round PCR. Amplification for the first round was performed for 35 cycles, with one cycle consisting of 94°C for 30 s, 58°C for 30 s, and 72°C for 3 min, followed by a final extension step at 72°C for 10 rain. Second round PCR reactions differed from first round reactions in that 40 cycles were used, primer annealing was at 64°C, and primer extension was for 2 rain. The primers used were as follows (nucleotide positions counted from the major transcription start site are shown in parentheses): COL11A2-1 (sense), 5'-CGGTGGATGGAAGCCGTCTGA (nucleotides 4507-4527); COL11A2.-2 (antisense), 5'-GTGACGTCATCCCTAGGCGT (nucleotides 4822-4803); COL11A2-6 (antisense), 5'-CGCCATGTCCTT-TCTCTTCTC (nucleotides 5456-5466); COL11A2-7 (sense), 5'-GGG-GGACCCA'I-IGGTCGCCA (nucleotides 3039-3058); COL11A2-8 (antisense), 5'-TCTCCATCCTCTCCAGCCAC (nucleotides 3217-3198); COL11A2-9 (sense), 5'-GGCTCATAGTCTGCTCCCTG (nucleotides 128-147); COL11A2-10 (sense), 5'-G GCCCAG'I-FGGAGACCCTGG (nucleotides 1221-1240); COL11A2-11 (antisense), 5'-CCAGGGTCTCCAG-TCGGTCC (nucleotides 2314-2295); COL11A2-12 (sense), 5'-CCCTCT-GGACCTCAGGGACC (nucleotides 2082-2101); COL11A2-13 (antisense), 5'-GCGCCATTGGGTCCAGCTGG (nucleotides 3541-3522); DDI (sense), 5'-AAGGAGAGCCTGCAGTGTTG (nucleotides 1117-1136); and PO2 (antisense), 5'-GAATGGGAGCATGAGAGATGT (nucleotides 1325-1305).
The sets of primers used were as follows: 9/11, DDI/8, DDI/13, 6•7, and 1/6 (for this primer pair, the second round conditions were used) for the first round and 9/PO2, 10/11,1 2/8, and 712 for the second round, respectively.
All PCR reactions were done in a total volume of 50 p_l containing 1 x PCR buffer, 200 p.M dNTPs, 0.5 p.M (each) primer, and 1 U of Taq polymerase. For SSCP and heteroduplex analyses, 0.5 p.I of [a-~P]dCTP (10 mM, 2000 Ci/mmol) was added to the reaction. All five fragments were cut into smaller fragments using a set of different restriction enzymes: (9/PO2: Fokl, Hinfl, Nlalll, Styl; 10/11: Aval, Fokl, Hinfl, Styl; 12/8: Apal, Fokl, Mspl, Styl; 7/2: Apal, Fokl, Hinfl, Styl; and 1/6: Alul, Fokl, Hinfl, Styl). The digested products as well as the undigested full-length products were loaded both on MDE gels and on 5o/o nondenaturing polyacrylamide SSCP gels (Warman et al., 1993) .
Fragments showing differences with either technique were further analyzed by dideoxy-nucleotide cycle sequencing (dsDNA Cycle Sequencing System, G IBCO-BRL) using ~P end-labeled primer. Secondround PCR primers were used for the sequencing reactions. For amplifying genomic DNA, an additional primer set was synthesized: COL11A2-16 (antisense): 5'-'I-rGGCTCCTTTGGGGCCAGC (nucleotides 4381-4362); COL11A2-17 (sense): 5'-CCCTGGGCAGAAGGGT-GAGA (nucleotides 4280-4299). Amplification conditions were 35 cycles at 94°C for 30 s, 58°C for 30 e, and 72°C for 1 min, with a final extension at 72°C for 10 min. The amplification product was also cycle seque~lced.
For analysis of the recessive syndrome, several pairs of PCR primers were used to amplify the a2(Xl) cDNA in seven overlapping fragments. In addition to primers that were used for analysis of the dominant syndrome , several other primers were also used, and they were as follows: COL11A2-14 (antisense), The first round of PCR was performed with the primer sets 9/11, 10/ 13, 13122, 21/27, 14115, and 1/6; for the second round, the PCR-nested primers were 9•32 (9/11-PCR used as a template), 12/8, and 23/10 (10/13-PCR used as a template). Amplification reactions and conditions were essentially the same as for the analysis of the dominant syndrome, except for minor adjustments of annealing temperature and extension times, as needed.
The PCR products were sequenced by cycle sequencing. Sequencing primers were as follows: COL11A2-2, For amplification of genomic DNA from members of the family with the recessive syndrome, primers 23133 were used to amplify a 1.2 kb product. This product was digested with Mspl, and the digest was analyzed by electrophoresis through 4% agarose. The products were also sequenced by cycle sequencing using primers COL11A2-23 and COL11A2-38 (intronic sequence, sense): 5'-TCCGGGAGGCTGGATA-GAAG.
Segregation of the Mutation with the Autosomal Dominant Phenotype
A primer, COL11A2-18 (sense): 5'-GGTATCCCAGGAGCATCCGG (nucleotides 4302-4321), was synthesized closer to the novel Nlalll site created bythe G to A transition, and PCR was used to amplify a 180 bp fragment from genomic DNA covering the mutation site (primers COL11A2-16 and COL11A2-18). 35 cycles, each performed at 94°C for 30 s, 62°C for 30 s, and 72°C for 40 s, were done with a final extension step at 72°C for 10 rain. The Nlalll site created by the mutation lies 55 bp downstream of the COL11A2-18 primer, whereas a Nlalll site in the wild-type sequence is 125 bp downstream. The COL11A2-18 primer was end labeled with 32p, and genomic DNAs of all family members were amplified with the primer pair. The PCR prod-uct was Nlaill digested and analyzed on a 5% denaturing polyacrylamide gel (Figure 2 ).
Linkage Analysis in the Family with Autosomal Recessive Osteochondrodysplasia
Genomic DNA was isolated from peripheral blood. To define the COL11A2 locus in 6p21.3 (Kimura et al., 1989) , we used CA repeat polymorphisms from 10 loci that are in the same or adjoining chromosome subband. PCR amplification of genomic DNA was used to analyze the marker loci using [(x-3=P]dCTP in order to label the amplified DNA. Allelic bands were separated on a 8.6% denaturing polyacrylamide gel and visualized by overnight exposure of the dried gel to Kodak X-OMAT S film. The Mlink program package (version 5.03)was used for the calculation of Iod scores (Lathrop et al., 1984) assuming autosomal recessive inheritance, in the calculations, the frequency of the disease allele and the frequencies of the marker alleles were varied as discussed in Results.
SSC and Mspl Polymorphisms within the COLllA2 Gene
The primer pair consisting of COL11A2-1 and COL11A2-2 was used to amplify an 898 bp genomic DNA fragment containing a 583 bp intron. Cycling conditions were 30 cycles of 95°C for 30 s, 58°C for 30 s, and 72°C for 1 min, with a 10 min 72°C final extension. SSC analysis of the full-length product identified a 3-allele pelymorphism (with allele frequencies 0.76, 0.03, and 0.21, from largest to smallest allele size). This polymorphism was used to incorporate the COL11A2 gene in the CEPH linkage map ( Figure 5 ). Of 38 CEPH pedigrees, 12 were informative for the COL11A2 SSC polymerphism. Pairwise and multipoint linkage analyses were performed between COL 11A2 and loci on human chromosome 6 (CEPH Database, version 7.0) using version 5.10 of the LINKAGE programs supplied by Dr. J. Ott (Lathrop et al., 1984) . Allele frequencies were determined by genotyping 31 CEPH grandparents. Sex-specific recombination rates for males and females were set to be equal (®m = ®f) for the pairwise linkage analysis. Two-point analysis was carried out using the CLODSCORE portion of the program, and locus order calculations were done using CILiNK. Final order testing was done by testing the inverted orders using CILINK.
Another polymorphism, detected during SSCP and heteroduplex analysis, created a novel Mspl restriction enzyme cutting site in the COL11A2 cDNA. Two primers were synthesized to amplify the region containing this polymorphism from genomic DNA: COL11A2-36 (antisense), 5LTGTAGGCCAATGGGTCCTGG (nucleotides 3436-3417) and COL11A2-37 (sense), 5'-TGTGGGGCAGCCTGGAGCAG (nucleotides 3308-3327). The PCR program used contained 30 cycles with 94°C for 30 s, 64°C for 30 s, and 72°C for 60 s, with a final extension at 72°C for 10 min. The length of the amplification product, when genomic DNA was used as template, was approximately 320 bp. The polymorphism creates a unique Mspl site in this fragment, forming two restriction fragments, 230 bp and 90 bp long ( Figure 4A ).
